Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemopreventive Effects of Mesalazine in Patients at High Risk of Recurrent (Nonfamilial) Colorectal Adenomas

NCT01894685 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT01894685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01894685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemopreventive Effects of Mesalazine in Patients at High Risk of Recurrent (Nonfamilial) Colorectal Adenomas
Lead sponsor
UMC Utrecht
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2012
Completion date
June 30, 2015
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sporadic colorectal adenoma